StoryFunding
Neuralink raises $280M Series D led by Founders Fund
Neuralink announced a $280M Series D funding round led by Founders Fund, a few months after receiving FDA approval for its first human study.
- $280M Series D led by Founders Fund
- Announced in August 2023, months after FDA study approval in May
- Funds support advancing first implant toward market
- Valuation estimated around $5 billion post-round